Drug Developement/Delivery
- FDA Approves First NASH Drug & Other Pipelines in Clinical Trials
- Lumisight (pegulicianine) Gains FDA Approval to Detect Residual Cancer
- Advances in Macrocyclic Peptide Drug Development
- Upcoming GLP-1 RAs for NASH: A Comprehensive List
- Targeted Therapies for Systemic Lupus Erythematosus (SLE)
- FDA Approved First HER2/HER3 Bispecific Antibody - Zenocutuzumab (Bizengri)
- Small Nucleic Acid Drugs Expected to Be Approved by 2025
- Diabetes & Weight Loss Drug Tirzepatide Now Approved for OSA (Obstructive Sleep Apnea)
- Long Acting GLP-1 Receptor Agonist Drugs Lists and Overview
- Semaglutide vs. Tirzepatide for Obesity